This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $311,341 to the University of Southern California to assess cost and non-cost barriers to the use of novel Alzheimer's disease (AD) and related dementia (ADRD) therapeutics among older Hispanic or Latino adults.
The project involves two main phases. The first phase will conduct semi-structured interviews with a cohort of Latino adults and Latino patients with AD/ADRD and their caregivers to inform a subsequent population-based survey to be administered through the Understanding America Study. These efforts will elucidate cost and non-cost factors influencing the demand and use of new dementia treatments in the older Hispanic/Latino adult population compared to non-Hispanic adults.
The second implementation phase will analyze Medicare claims and encounter data to understand real-world use patterns, and then use a dynamic microsimulation model to estimate the downstream impacts of use on cognitive/physical health, costs, and quality of life for older Hispanic/Latino adults with dementia. The project runs from Sep 2024 through Aug 2026.
Generated 7/1/25, 3:39 AM